IXHL

3.21% -0.0199

Handel nachbörslich: .60 -0.000100 -0.02%

Incannex Healthcare Inc (IXHL)

Überblick Nachrichten Preisverlauf Warum fällt IXHL? Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Incannex Healthcare Inc Stock (IXHL) Company Profile

Incannex Healthcare Inc

Healthcare (1151)

61 409 840 786

401 DOCKLANDS DRIVE, DOCKLANDS, VICTORIA

Nächster Verdiensttermin

Neueste SEC-Einreichungen

IXHL's Discussions on Twitter

Vergleichen Sie IXHL mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
IXHL Incannex Healthcare Inc	0.6001	17.91M	0	-21.91M	0	-1.49
ZTS Zoetis Inc	148.67	67.28B	9.26B	2.49B	2.30B	5.47
HLN Haleon Plc Adr	10.22	45.62B	14.35B	1.85B	0	0.4023
TAK Takeda Pharmaceutical Co Adr	14.71	45.01B	30.25B	1.37B	5.08B	0.4257
TEVA Teva Pharmaceutical Industries Ltd Adr	13.65	15.60B	16.54B	-1.64B	749.00M	-1.45
UTHR United Therapeutics Corp	284.73	12.77B	2.76B	1.11B	898.10M	22.77

Incannex Healthcare Inc Aktie (IXHL) Neueste Nachrichten

Finanzdaten der Incannex Healthcare Inc-Aktie (IXHL)

Incannex Healthcare Inc (IXHL)

Incannex Healthcare Inc Stock (IXHL) Company Profile

Vergleichen Sie IXHL mit anderen Aktien

Incannex Healthcare Inc Aktie (IXHL) Neueste Nachrichten

Incannex Healthcare (NASDAQ:IXHL) Trading Down 19% – Here’s Why - Defense World

Incannex enters agreement for potential stock sales - Investing.com Australia

Incannex enters agreement for potential stock sales By Investing.com - Investing.com South Africa

IXHL Stock Touches 52-Week Low at $0.64 Amid Market Challenges - Investing.com

Incannex Healthcare Completes Phase 2 Enrollment In Reposa Phase 2/3 Trial Of Ihl-42X, An Oral Once-Daily Treatment For Obstructive Sleep Apnea (Osa) - MarketScreener

Incannex Healthcare Completes Phase 2 Enrollment in RePOSA Phase 2/3 Trial of IHL-42X, an Oral Once-Daily Treatment for Obstructive Sleep Apnea (OSA) - TradingView

IXHL stock touches 52-week low at $0.73 amid market challenges - Investing.com

Incannex Healthcare files to sell 65.97M shares of common stock for holders - MSN

Incannex Healthcare Inc. (NASDAQ:IXHL) Sees Significant Decrease in Short Interest - The AM Reporter

Incannex Healthcare Repays Convertible Debenture in Full - TipRanks

Weekly Roundup on the Cannabis Sector & Psychedelic Sector - marketexclusive.com

IXHL Stock Touches 52-Week Low at $0.73 Amid Market Challenges - Investing.com Australia

IXHL Stock Touches 52-Week Low at $0.73 Amid Market Challenges By Investing.com - Investing.com South Africa

Incannex Healthcare announces $12.5 million offering - Green Market Report

Incannex Healthcare Inc. Announces Pricing of $12.5 Million Private Placement Priced at the Market Under Nasdaq Rules - The Manila Times

Incannex Healthcare Inc. Announces Pricing Of $12.5 Million Private Placement Priced At The Market Under Nasdaq Rules - Marketscreener.com

Incannex Healthcare Inc. Announces $12.5 Million Offering of Common Stock and Series A Warrants - Nasdaq

Can This $12.5M Deal Push Incannex's Sleep Apnea Treatment to Phase 3? - StockTitan

IXHL stock touches 52-week low at $1.09 amid market challenges - Investing.com Australia

Incannex OSA Drug Candidate IHL-42X Sails Through Milestones - Sleep Review

IXHL stock touches 52-week low at $1.49 amid market challenges By Investing.com - Investing.com South Africa

IXHL stock touches 52-week low at $1.49 amid market challenges - Investing.com UK

Incannex Healthcare Limited Reports Quarterly Financials - TipRanks

Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 2Q 2025 - The Kingston Whig-Standard

Biotech Earnings Alert: Incannex Secures $50M Financing as R&D Costs Drop 46% - Stock Titan

Incannex Healthcare Inc. Reports Fiscal Second Quarter 2025 Financial Results and Business Updates - Defense World

Incannex Healthcare Reports Fiscal Second Quarter Results -February 14, 2025 at 08:49 am EST - Marketscreener.com

Incannex Healthcare Inc. SEC 10-Q Report - TradingView

Incannex Healthcare Appoints Alison Wimms, Ph.D. to its Newly Formed IHL-42X Obstructive Sleep Apnea Clinical Advisory Board - Defense World

Incannex Forms Clinical Advisory Board to Guide IHL-42X Sleep Apnea Drug Development - Sleep Review

Incannex Healthcare Appoints Alison Wimms, Ph.D. to Newly Formed IHL-42X Obstructive Sleep Apnea (OSA) Clinical Advisory Board - The Manila Times

Incannex Healthcare Inc. Announces the Appointment of Alison Wimms as an Advisor to Its Newly Formed Ihl-42X Obstructive Sleep Apnea Clinical Advisory Board - Marketscreener.com

Sleep Medicine Pioneer Joins Incannex's Revolutionary OSA Treatment Development - StockTitan

Incannex Healthcare Announces Positive Topline Results from PK Study - Defense World

Incannex Reports Positive Data for OSA Drug Candidate IHL-42X - Sleep Review

Incannex Healthcare Announces Positive Topline Results from Pharmacokinetics (PK) Study of IHL-42X, an Oral Combination Medicine for the Treatment of Obstructive Sleep Apnea - The Manila Times

Incannex Reports Strong Results for Sleep Apnea Drug IHL-42X in Key Clinical Study - StockTitan

Incannex Healthcare faces Nasdaq delisting over market value By Investing.com - Investing.com South Africa

Incannex Healthcare faces Nasdaq delisting over market value - Investing.com

Reviewing Alterity Therapeutics (NASDAQ:ATHE) and Incannex Healthcare (NASDAQ:IXHL) - Defense World

IXHLIncannex Healthcare Limited American Depositary Shares Latest Stock News & Market Updates - StockTitan

Incannex Healthcare Inc. Receives Notice of Listing Deficiency from NasdaqOn January 3, 2025, Incannex Healthcare Inc. (NASDAQ: IXHL) received a written notice from The Nasdaq Stock Market LLC stating that the company is not in compliance with Nasda - Defense World

U.S. Energy (NASDAQ:USEG) Shares Cross Above 200 Day Moving Average – What’s Next? - Defense World

Financial Security Advisor Inc. Has $12.95 Million Position in Microsoft Co. (NASDAQ:MSFT) - Defense World

Finanzdaten der Incannex Healthcare Inc-Aktie (IXHL)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie IXHL